Sino Biopharmaceutical | 1177 - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Akebia Therapeutics 362.52M 357.69M 2026-03
Alaunos Therapeutics USD 1.07M 215K 2023-06
Avita Medical AUD 1.25M 100K 2025-06
Cspc Pharmaceutical CNY 6.76M 3.43M 2025-12
Dianthus Therapeutics USD 4.44M 263K 2024-09
Ionis Pharmaceuticals USD 18M 1000K 2026-06
IQVIA Holdings USD 192M 1000K 2026-03
Jiangsu Hengrui CNY 254.59M 253.85M 2025-09
Moderna USD 10.96B 527M 2026-06
Organon & Co USD 111M 17M 2026-03
Revvity USD 24.72M 1.2M 2026-03
Sino Biopharmaceutical CNY 76.87M 114.23M 2024-06
Tectonic Therapeutic USD 246.58M 246.56M 2026-03
Viatris USD 120.1M 500K 2026-03
Xeris Pharmaceuticals USD 6.88M 269K 2026-03